Imperial Valley News Center
FDA approves first artificial iris
- Details
- Written by Angela Stark
Washington, DC - The U.S. Food and Drug Administration today approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part of the eye around the pupil) is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye.
Secretary of State Mike Pompeo's Call With Russian Foreign Minister Sergey Lavrov
- Details
- Written by State Department
Washington, DC - Secretary Pompeo and Russian Foreign Minister Sergey Lavrov spoke by phone today, their first conversation since the Secretary’s swearing in and the Foreign Minister’s reappointment.
Signing of the Right to Try Act
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D.
Washington, DC - For patients with serious or immediately life-threatening diseases, the FDA remains committed to enhancing access to promising investigational medicines for those unable to access products through clinical trials. This is the mission of our expanded access program. The agency is dedicated to these purposes, and it has been for more than three decades.
Secretary of State Mike Pompeo's Meeting With Hungarian Foreign Minister Szijjarto
- Details
- Written by State Department
Washington, DC - Secretary Michael Pompeo met with Hungarian Foreign Minister Peter Szijjarto in Washington on Wednesday. The two discussed areas of mutual interest and opportunities for our countries to increase cooperation. The Secretary underscored the importance of maintaining a vibrant civil society.
Alternative Manure Management Program
- Details
- Written by IVN
Sacramento, California - The California Department of Food and Agriculture (CDFA) Office of Environmental Farming and Innovation is now accepting new dairy and livestock manure management practices for consideration in the Alternative Manure Management Program (AMMP). The goal of this effort is to improve program effectiveness and increase stakeholder engagement.
FDA approves new treatment for moderately to severely active ulcerative colitis
- Details
- Written by IVN
Washington, DC - The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication. Other FDA-approved treatments for the chronic treatment of moderately to severely active ulcerative colitis must be administered through an intravenous infusion or subcutaneous injection.
Page 1317 of 3785